We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.

I Agree

You are here: Industry Insights > ProBioGen AG

News List

The life science and biotech PR distribution service PharmaSources
May 06, 2024
Alfred Merz, PhD, has been appointed as Chief Operating Officer effective May 1st, 2024.
ProBioGen’s GlymaxX Technology Reaches Phase III Development contractpharma
December 17, 2021
Zymeworks recently announced a global Phase III clinical trial of zanidatamab in HER2‑expressing gastroesophageal cancer.
ProBioGen AG Appoints Dr. Lutz Hilbrich as New Chief Executive Officer - Dr. Wieland Wolf Retires b3cnewswire
May 06, 2020
ProBioGen AG, a premier, Berlin-based CDMO for developing and manufacturing complex therapeutic glycoproteins today announced that Dr. Lutz Hilbrich, an experienced biotech executive, has been named Chief Executive Officer, effective June 1, 2020.
Immunogenesis Contracts ProBioGen for Development and Large-Scale Manufacturing Services b3cnewswire
March 25, 2020
ProBioGen AG today announced that Immunogenesis, Inc., a spin-off of the MD Anderson Cancer Center, University of Texas, has signed a Service Agreement for Cell Line Development, Process Development and GMP Manufacturing in 1,000 L bioreactor scale for th